Profound Medical Corp (PRN)

19.61
+0.62(+3.26%)
  • Volume:
    44,932
  • Bid/Ask:
    19.60/19.72
  • Day's Range:
    18.66 - 19.87
  • Type:Equity
  • Market:Canada
  • ISIN:CA74319B5027
  • CUSIP:74319B502

PRN Overview

Prev. Close
18.99
Day's Range
18.66-19.87
Revenue
16.44M
Open
19.06
52 wk Range
16.79-36.73
EPS
-1.84
Volume
44,932
Market Cap
402.23M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
27,680
P/E Ratio
-
Beta
1.6
1-Year Change
-11.31%
Shares Outstanding
20,386,802
Next Earnings Date
Nov. 11, 2021
What is your sentiment on Profound Medical Corp?
or
Market is currently closed. Voting is open during market hours.

Profound Medical Corp News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyNeutral

Profound Medical Corp Company Profile

Profound Medical Corp Company Profile

Employees
109
Market
Canada

Profound Medical Corp. is a commercial-stage medical device company. focused on customizable, incision-free therapies which combine real-time magnetic resonance imaging (MRI), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. The Company’s products include TULSA-PRO System and SONALLEVE. The TULSA-PRO is used to ablate benign or malignant prostate tissue in patients with a variety of prostate diseases. Prostate diseases include prostate cancer and benign prostatic hyperlasia (BPH). Prostate cancer is one of the common types of cancer affecting men. TULSA-PRO and SONALLEVE share the common technological concept of using MRI to enable visualization of the surgeon desired tissue in real time. Both products also use thermal ultrasound technology to heat and ablate tissue.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.